Literature DB >> 16725983

Induction of parturition in swine with a prostaglandin analog and oxytoxin: A trial involving dose of oxytocin and parity.

C Welp1, W Jöchle, W Holtz.   

Abstract

The purpose of this experiment was to compare a range of oxytocin doses in order to find the most suitable dose to improve predictability and precision of timing of PGF-induced parturition in sows. Sows randomly allotted to 6 groups - group size varying between 28 and 39 - were either untreated controls (group 1) or received an IM injection of 2 mg of the PGF-analog Alfaprostol (Vetem) on day 111 of pregnancy (day 0 = last day of standing heat), followed 20 h later by 0, 5, 10, 20 or 30 IU oxytocin, respectively (groups 2 - 6). Both length and variability of the time from injection of oxytocin to the onset of parturition decreased with increasing dose. The response was faster and more predictable with older sows than with first litter gilts. A disadvantage of higher doses of oxytocin was the necessity of manual aid (11 % in controls, 52 % with the maximum level of 30 IU oxytocin). Litter size, weight and percentage of piglets weaned and time from weaning to subsequent estrus were not affected by any of the treatments. An oxytocin dose of 20 IU applied 20 h after PGF appeared to give the most effective response, although this will occasionally necessitate manual assistance with parturition.

Entities:  

Year:  1984        PMID: 16725983     DOI: 10.1016/0093-691x(84)90050-5

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  2 in total

1.  Effect of propranolol on the onset and duration of parturition in sows.

Authors:  R N Kirkwood; P A Thacker
Journal:  Can Vet J       Date:  1995-04       Impact factor: 1.008

Review 2.  Defining the Effect of Oxytocin Use in Farrowing Sows on Stillbirth Rate: A Systematic Review with a Meta-Analysis.

Authors:  Sarah V Hill; Maria Del Rocio Amezcua; Eduardo S Ribeiro; Terri L O'Sullivan; Robert M Friendship
Journal:  Animals (Basel)       Date:  2022-07-13       Impact factor: 3.231

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.